Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma-Reference-Cited by-同舟云学术

Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma

Published:2023-02-21 Issue:7 Volume:50 Page:2152-2166
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Jinghua Li,Kui Xu,Deliang Guo,Bo Liao,Qian Zhu,Haitao Wang,Yaqun Jiang,Dongde Wu,Xigang Xia,Ping Jiang,Shengli Tang,Zhiyong Yang,Yueming He,Zhonglin Zhang,Yong He,Yufeng Yuan

Funder

Key Research and Development Program of Hubei Province

Research Fund of the Health Commission of Hubei Province

Cancer research and translational platform project of Zhongnan Hospital of Wuhan University

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-023-06137-z.pdf

Reference30 articles.

1. Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma Nat Rev Dis Primers. 2021;7:65. https://doi.org/10.1038/s41572-021-00300-2.

2. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349–69. https://doi.org/10.1002/cncr.29692.

3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. https://doi.org/10.3322/caac.21708.

4. Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvise M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):98–107. https://doi.org/10.1111/liv.14086.

5. Schooler GR, Hull NC, Lee EY. Hepatobiliary MRI contrast agents: pattern recognition approach to pediatric focal hepatic lesions. AJR Am J Roentgenol. 2020;214:976–86. https://doi.org/10.2214/AJR.19.22239.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CT;EJNMMI Research;2024-09-11

2. Diagnostic Performances of PET/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review;International Journal of Molecular Sciences;2024-06-29

3. Diagnostic Performance of FAPI PET/CT vs. <sup>18</sup>F-FDG PET/CT in Evaluation of Liver Tumors: A Systematic Review and Meta-analysis;Molecular Imaging and Radionuclide Therapy;2024-04-16

4. Head-to-head comparison of [68Ga]Ga-FAPI PET and [18F]FDG PET in the detection of bone and lymph node metastasis in various cancers: A systematic review and meta-analysis;European Journal of Radiology;2024-02

5. How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers;Seminars in Nuclear Medicine;2023-12